Scientists have developed a next-generation RNA approach that shows promise in treating thousands of genetic diseases previously considered untreatable by current drug therapies.
The method acts as a biological bypass, allowing researchers to address specific genetic mutations that were previously missed by conventional mRNA-based treatments.
Clinical trials are expected to follow, with experts noting that this breakthrough could revolutionize the management of rare hereditary conditions within the next decade.